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Abstract 
14-3-3 proteins appear to play a critical role in Ca”-stimulated secretion in pezmeabtid chromafi cells. 14-3-3 proteins have been reported 
to he both stimulators and inhibitors of protein kinase C (PKC). We have found that 14-3-3 proteins, isolated on the basis of their ability to enhance 
secretory activity, stimulated histone phosphorylation by PKC, but they had no effect on myosin light chain phosphorylation by PKC. 14-3-3 proteins 
were also found to inhibit the rate of [‘*P]histone dephosphorylation but not he rate of [32P]myosin light chain dephosphorylation. Cross-linking 
experiments and affinity chromatography demonstrated that 14-3-3 proteins bind to histones. These results uggest that at least some of the reported 
effects of 14-3-3 proteins on PKC activity may result from 14-3-3 proteins binding to histone. 
Key woruk 14-3-3 protein, Protein phosphatase; Protein kinase C; Secretion 
1. Introduction 
Catecholamine secretion by digitonin-permeabilized 
chromati cells is both ATP- and Ca”-dependent. Incu- 
bation of these permeabilized cells in the absence of Ca” 
results in a progressive loss of proteins and secretory 
activity [l]. The addition of cytosolic proteins prevents 
this loss of Ca2+-dependent secretion [1,2]. 14-3-3 pro- 
teins (or Exol) appear to play a key role in this restora- 
tion [3,4], but their precise role in the secretory processes 
remains to be determined. 
14-3-3 proteins are acidic, dimeric proteins with sub- 
units of 27-30 kDa [5]. They are most abundant in brain 
but are present at lower levels in a variety of other tissues 
[6,7]. 14-3-3 proteins can activate both tyrosine and tryp- 
tophan hydroxylases [8]. Stimulation of these hydrox- 
ylases can not account for the effect of 14-3-3 proteins 
on Ca2+-dependent secretion [3,4], and 14-3-3 proteins 
are in tissues which also do not contain hydroxylase [6,7]. 
It has been reported that a Ca”-sensitive phospholipase 
A2 is a form of 14-3-3 protein [9]. However, 14-3-3 pro- 
teins, isolated on the basis of their ability to stimulate 
secretion, have no significant phospholipase A2 activity 
([lo] and Chen and Wagner, unpublished results). 
Toker et al. [11,12] have reported that 14-3-3 proteins 
inhibit protein kinase C (PKC) and have called them 
KCIPs, for kinase C inhibitor proteins. In contrast, 
Isobe et al. [13] have reported that 14-3-3 proteins stim- 
ulate PKC activity. Morgan and Burgoyne [14] found 
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that 14-3-3 proteins, isolated on the basis of their ability 
to stimulate secretion (Exol), have no effect on PKC 
activity. 
Because an increase in the level of protein phosphoryl- 
ation tends to increase Ca’+-dependent secretion in per- 
meabilized chromaffm cells [3,15], in the present investi- 
gation we examined the possibility that 14-3-3 proteins 
might inhibit protein phosphatases. We found that 
14-3-3 proteins, isolated on the basis of their ability to 
stimulate secretion, inhibited the rate of histone 
dephosphorylation, but they had no effect on the rate of 
myosin light chain dephosphorylation. We also found 
that 14-3-3 proteins stimulated histone phosphorylation 
by PKC but not myosin light chain phosphorylation by 
PKC. Cross-linking experiments and affinity chromatog- 
raphy showed that 14-3-3 proteins bind to histones. 
These results suggest that least some of the effects of 
14-3-3 proteins on histone phosphorylation and 
dephosphorylation may result from 14-3-3 proteins bind- 
ing to histone. Toker et al. [11,12] and Isobe et al. [13], 
but not Morgan and Burgoyne [14], used histone as the 
substrate for PKC. 
2. Material and methods 
PC12 cells were cultured as described previously [16]. 14-3-3 proteins 
were isolated from either bovine brain or adrenal medulla on the basis 
of their ability to enhance Ca”-stimulated secretion [4]. PKC was 
isolated from bovine brain [17]. The catalytic subunit of protein phos- 
phatase 2A [18], smooth muscle myosin light chains [19], and myosin 
light chain kinase [20] were isolated from turkey gizzards. 
PC12 cells were lysed by incubation in 5 mM EDTA and 5 mM 
Tris-HCl, pH 7.5 (lo5 cells/35 ~1) for 5 min at room temperature [21]. 
The lysed cells were centrifuged for 5 min at 12,000 x g, and the soluble 
fraction used for protein phosphatase assays. Extracts from 7 x Iti cells 
were incubated in 100 ~1 of 50 mM Tris-HCl, pH 7.5, 2 mM EDTA, 
0.5 mM dithiothreitol, 3 ,uM ‘%‘-phosphorylated histone (approxi- 
mately 0.5 mol 32P/mol histone) or 2 PM ‘?-phosphorylated myosin 
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regulatory light chains (approximately 0.5 mol ‘*P/m01 light chain) at 
30°C for 5 min 121.221. and the amounts of “PO. released etermined 
[23]. Less than i5sb gf the phosphorylated hi&es or myosin light 
chains were dephosphorylated, and the rates of dephosphorylation 
were linear. Histone (Sigma, type III-S) was phosphorylated by CAMP- 
dependent protein kinase (Sigma) [24] and myosin light chains by 
myosin light chain kinase [20]. Myosin light chains phosphorylated by 
myosin light chain kinase and histone phosphorylated by CAMP-de- 
pendent protein kinase are good substrates for both protein phosphat- 
ase 1 and protein phosphatase 2A [18,21,22,25], the two most abundant 
serine/threonine-specific protein phosphatases [26]. 
The assay buffer used for measuring PKC activity (60 ~1 total 
volume) contained 20 mM HEPES, pH 7.4, 1 mM dithiothreitol, 0.33 
mM EDTA, 0.33 mM EGTA, 1.7 mM CaCl,, 10 mM MgCl,, 1 mM 
[~-3zplATP (2 x lo4 cpm/nmol), 200 &ml phosphatidylser&e,-1 &ml 
PKC 117l and either 0.25 ma/ml histone (Simna: tvne III-S). 0.25 ma/ml 
myosm regulatory light chains, or 25 $ml ‘of-a synthetic pepgde, 
VRKRTLRRL, that is a specific substrate for PKC [271. After a 10 min 
incubation at 3O”C, the reactions were terminated, and the amount of 
‘%‘G4 incorporated into histone [13,17], myosin light chain [28], or 
synthetic peptide [29] determined. 
Conditions used for cross-linking were 0.1 M triethanolamine, pH 
8.5, 4 mM EDTA, 2 mg/ml dimethyl suberimidate, 0.1 ma/ml 14-3-3 
proteins, and either 0.1 &/ml histone Hl (Boehringer-M&hen@ or 
0.1 mg/ml [32P]histone Hl. After 30 min at 37’C, the reactions were 
terminated by the addition of 50 mM Tris, pH 8.5. Cross-linked prod- 
ucts were examined by SDS-PAGE and autoradiography. Cross-link- 
ing experiments were also performed with histone type III-S (Sigma). 
The results were identical to those obtained with histone Hl exceut he 
histones were more heterogeneous and, consequently, gave more bands 
when examined by SDS-PAGE. 
Histone (3 mg; Sigma; type III-S) was coupled to 1 ml CNBr-acti- 
vated Sepharose (Pharmacia) following the manufacturer’s instruc- 
tions. 
3. Results and discussion 
3.1. Effect of 14-3-3 proteins on protein phosphatase 
activity 
The rate of [32P]histone dephosphorylation by a solu- 
ble extract of PC12 cells was inhibited 35% by the addi- 
tion of 100 ,~g/ml 14-3-3 proteins, but the rate of 
[32P]myosin light chain dephosphorylation was not inhib- 
ited by 14-3-3 proteins (Table 1). The rate of [32P]histone 
dephosphorylation by this cell extract was not inhibited 
by boiled 14-3-3 proteins or by similar concentrations of 
bovine serum albumin, calmodulin, or calpactin. As 
shown in Fig. 1, 50 &ml 14-3-3 protein gave maximal 
inhibition of histone dephosphorylation, and 12.5 ~&ml 
gave about half maximal inhibition. This concentration 
range for 14-3-3 proteins is similar to those reported for 
Table 1 
Effect of 14-3-3 proteins on the protein phosphatase activity in PC12 
cell extracts 
Substrate pm01 32P04 released/5 min 
Control + 100 &ml 14-3-3 oroteins 
[‘*P]histone 13.0 + 0.9 8.7 f 0.6 
[‘*P]myosin light chain 13.3 f 0.1 13.2 f 1.0 
Data are means + S.D. for three trials. Assays were performed as de- 
scribed in section 2. 
7 
. . 0 
A. 
50 
I I I * I 
0 50 100 150 200 
14-3-3 proteins (pglml) 
Fig. 1. Inhibition of protein phosphatase activity by 14-3-3 proteins. 
The protein phosphatase activity of a PC12 cell extract was determined 
as described in section 2 using 3 ,uM [‘*P]histone as a substrate in the 
presence of the indicated concentrations of 14-3-3 proteins. Rates are 
expressed relative to that obtained in the absence of added 14-3-3 
proteins. Data are means f S.D. for three trials. 
both the inhibition [l l] and the stimulation [13] of his- 
tone phosphorylation by PKC and for the stimulation of 
catecholamine secretion [3,4]. As the phosphatase assays 
were performed in 2 mM EDTA, most of the phosphat- 
ase activity in the PC12 cell extract is presumably due to 
protein phosphatase 1(PPl) and protein phosphatase 2A 
(PP2A) [26]. Experiments with inhibitor-2 (a protein that 
inhibits PPl but not PP2A) and okadaic acid (an inhibi- 
tor of protein phosphatases that can be used to distin- 
guish between PPl and PP2A) [26] indicated that the 
addition of 14-3-3 proteins to PC12 cell extracts partially 
inhibited the activities of both PPl and PP2A towards 
[32P]histone (data not shown). 14-3-3 proteins also gave 
40% inhibition in the rate of histone dephosphorylation 
by the isolated catalytic subunit of PP2A; 7.3 f 0.7 pmol 
32P0, was released from [32P]histone in the absence of 
14-3-3 proteins, and 4.2 f 0.1 pmol 32P04 was in the 
presence of 100 ,~g/ml 14-3-3 proteins. In contrast, the 
dephosphorylation of myosin light chains by purified 
PP2A was not affected by 14-3-3 proteins; 10.1 + 0.1 
pmol 32P0, was released from [32P]light chains in the 
absence of 14-3-3 proteins, and 10.6 & 0.8 pmol in the 
presence of 100 @ml 14-3-3 proteins. 
The amount of inhibition of protein phosphatase ac- 
tivity by 14-3-3 proteins depended on histone concentra- 
tion. When 2.5 PM [32P]histone was used, 100 &ml 
14-3-3 proteins (3.3 PM) gave about 50% inhibition of 
protein phosphatase activity in PC12 cell extracts, but 
when 10 PM [32P]histone was used, 100 &ml 14-3-3 
proteins gave only about a 20% inhibition of protein 
phosphatase activity. 
The observations that (i) 14-3-3 proteins inhibited his- 
tone dephosphorylation but not myosin light chain 
130 
dephosphorylation, (ii) 14-3-3 proteins partially inhib- 
ited histone dephosphorylation by both PPl and PP2A, 
and (iii) the extent of inhibition of histone 
dephosphorylation by 14-3-3 proteins depended on the 
histone concentration, all suggest that the inhibition of 
histone dephosphorylation by 14-3-3 proteins might re- 
sult from an interaction of 14-3-3 proteins with histone 
rather than with the protein phosphatases. 
3.2. Effect of 14-3-3 proteins on PKC activity 
While Toker et al. [l 1,121 have reported that 14-3-3 
proteins (KCIPs) inhibit PKC, Isobe et al. [13] have 
reported that 14-3-3 proteins stimulate PKC. Both 
groups used histone as a substrate for PKC. The reason 
for this difference in the effect of 14-3-3 proteins on 
histone phosphorylation by PKC is not clear, but it is 
possible that different isoforms of 14-3-3 proteins have 
different effects on histone phosphorylation by PKC. 
There are at least seven [30,31] and perhaps twelve [lo] 
different isoforms of 14-3-3 proteins. The KCIPs prepa- 
ration of Toker et al. [12] contains at least seven isoforms 
(a-q) of 14-3-3 proteins. Isobe et al. [13] used three dif- 
ferent purified isoforms (5, /3, and E), As shown in Table 
2, 14-3-3 proteins, isolated on the basis of their ability to 
stimulate secretion, stimulated histone phosphorylation 
by PKC almost two-fold, a result nearly identical to that 
obtained by Isobe et al. [13] with purified isoforms of 
14-3-3 proteins. However, these 14-3-3 proteins had little 
or no effect on myosin light chain phosphorylation by 
PKC (Table 2). Morgan and Burgoyne [14] used a syn- 
thetic peptide substrate specific for PKC to examine the 
effect of 14-3-3 proteins (Exol) on PKC activity. They 
found that 14-3-3 proteins had no effect on the phospho- 
rylation of this peptide by PKC. We also found that 
under the same assay conditions in which 14-3-3 proteins 
stimulated histone phosphorylation by PKC, 14-3-3 pro- 
teins had no effect on the phosphorylation of this peptide 
by PKC (Table 2). Like the KCIPs preparation of Toker 
et al. [11,12], our preparations of 14-3-3 proteins [4] and 
that of Morgan and Burgoyne [3,14] are heterogeneous 
and contain a variety of isoforms. At this time it is not 
known why KCIPs inhibit histone phosphorylation by 
Table 2 
Effect of 14-3-3 proteins on protein kinase C activity 
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PKC and our preparation of 14-3-3 proteins stimulate 
histone phosphorylation by PKC. However, it is possible 
that KCIPs contain an isoform of 14-3-3 proteins that is 
not present in our preparation of 14-3-3 proteins or that 
it is present in too low a concentration to inhibit histone 
phosphorylation by PKC. 
In agreement with the results of Isobe et al. [13] and 
Morgan and Burgoyne [14], we observed no significant 
phosphorylation of 14-3-3 proteins by PKC (data not 
shown). Toker et al. [12], however, found that at least 
some of their 14-3-3 proteins are substrates for PKC. 
The observation that 14-3-3 proteins affect PKC phos- 
phorylation of histone but not PKC phosphorylation of 
either myosin light chain or a synthetic peptide suggests 
that 14-3-3 proteins might interact with histone and alter 
its rate of phosphorylation by PKC. 
3.3. 14-3-3 proteins bind to histones 
The interaction of 14-3-3 proteins with histone was 
examined using the chemical cross-linker dimethyl 
suberimidate (Fig. 2). As expected from their dimeric 
structure, treatment of 14-3-3 proteins alone with this 
cross-linker generated a species with a molecular weight 
on SDS-PAGE of about 60 kDa (Fig. 2A, lane 2). Treat- 
ment of unlabeled histone (Fig. 2A, lane 4) or [32P]his- 
tone (Fig. 2B, lane 2) alone with this cross-linker esulted 
in little, if any, cross-linking of histone to itself. Fig. 2B 
is an autoradiogram and therefore only [32P]histone is
detected. When a mixture of 14-3-3 proteins and histone 
were treated with the cross-linker, a species of about 100 
kDa was formed (Fig. 2A, lane 3) and there was much 
less of the 60 kDa product than was obtained when 
14-3-3 proteins were cross-linked by themselves. Fig. 2B 
shows that the 100 kDa species contained histone (lane 
3) and that a large fraction of the [32P]histone had been 
cross-linked. Thus, the 100 kDa product appears to be 
a dimer of 14-3-3 proteins cross-linked to histone( The 
precise amount of cross-linking of histones to 14-3-3 
proteins was somewhat variable, ranging from a low of 
about 40% to almost complete cross-linking. The cross- 
linking experiments hown in Fig. 2 were performed in 
the presence of 2 mM EDTA. Similar results were ob- 
Substrate mnol 9’0~ incorporated/min/mg PKC 
Control + 100 &nl 14-3-3 proteins 
Histone in the presence of Ca/PL 650 f 20 1,230 + 50 
Histone in the absence of WPL 100 f 10 llOf.20 
Myosin light chain in the presence of Ca/PL 510 f 30 580 + 50 
Peptide VRKRTLRRL in the presence of CWPL 1,200 + 50 1,140 + 70 
Data are means + S.D. for three trials. Assays were performed as described in section 2 either in the presence or absence of 1.67 mM CaC& and 
200 &ml phosphatidylserine (Ca/PL). 
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Fig. 2. Cross-linking of 14-3-3 proteins to histone Hl. Cross-linking reactions were performed as described in section 2. (A) Samples eparated by 
SDS-PAGE and stained with Coomassie brilliant blue: lanes (1) 14-3-3 proteins not treated with the cross-linker dimethyl suberimidate, (2) 14-3-3 
proteins treated with dimethyl suberimidate, (3) 14-3-3 proteins and histone Hl treated with dimethyl suberimidate, (4) histone Hl treated with 
dimethyl suberimidate, and (5) histone Hl not treated with dimethyl suberimidate. (B) Samples separated by SDS-PAGE and [‘%]histone Hl detected 
by autoradiography: lanes (1) [“PJhistone Hl not treated with dimethyl suberimidate, (2) [‘*P]histone Hl treated with dimethyl suberimidate, 
(3) [3?]histone Hl and 14-3-3 proteins treated with dimethyl suberimidate, and (4) [32P]histone Hl and 14-3-3 proteins not treated with dimethyl 
suberimidate. 
tamed in the presence of 1.7 mM CaCl, and 10 mM 
M&l,. 
14-3-3 proteins were also reacted with dimethyl suber- 
imidate in the presence of either 0.1 mg/ml 32P-labeled 
myosin light chain or 3 pg/ml PKC autophosphorylated 
with [Y-~*P]ATP. The reaction products were separated 
by SDS-PAGE and examined by autoradiography. 
There was no detectable cross-linking of 14-3-3 proteins 
to either myosin light chains or PKC (data not shown). 
Immobilized histone was also used to look for an in- 
teraction between 14-3-3 proteins and histones. 14-3-3 
proteins were applied to either a histone-Sepharose col- 
umn or a control column (CNBr-activated Sepharose 
reacted with ethanolamine) in a low salt buffer (Fig. 3). 
While most of the 14-3-3 proteins did not bind to the 
control column, more than 75% bound to the histone 
column. The 14-3-3 proteins which bound to the histone 
column were not eluted by 0.1 M NaCl but were eluted 
by 1 M NaCl (Fig. 3). 
The results presented here show that 14-3-3 proteins 
can bind to histone. This is not unexpected as histones 
are basic proteins and 14-3-3 proteins are acidic. Other 
acidic proteins such as cahnodulin can also bind to his- 
tones [32]. However, we found that, unlike 14-3-3 pro- 
teins, calmodulin had no effect on histone phosphoryla- 
tion by PKC (580 nmol 32P incorporated into histone/ 
min/mg PKC in the presence and absence of 100 ,@ml 
cahnodulin), and it did not inhibit histone 
dephosphorylation by PC12 cell extracts. Whether there 
is any physiological significance to the binding of 14-3-3 
proteins to histones is not known, but 14-3-3 proteins in 
non-mammalian cells have been postulated to be in- 
volved in regulating gene expression (reviewed in [31]). 
The binding of 14-3-3 proteins to histone provides an 
explanation as to why 14-3-3 proteins affect both the 
phosphorylation and dephosphorylation of histones but 
not the phosphorylation and dephosphorylation of 
myosin light chains. 
Because 14-3-3 proteins did not inhibit myosin light 
chain dephosphorylation or stimulate myosin light chain 
phosphorylation by PKC, it seems unlikely that 14-3-3 
proteins act either as general inhibitors of protein 
phosphatases or as general stimulators of PKC. How- 
ever, it is possible that 14-3-3 proteins affect secretion by 
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Fig. 3. Binding of 14-3-3 proteins to histone-Sepharose. 700 pl of 100 
&ml 14-3-3 proteins were applied to a 1 ml column of either histone- 
Sepharose (0) or ethanolamine-Sepharose (0) equilibrated in 50 mM 
Tris, pH 7.5, 2 mM EDTA, and 0.5 mM dithiothreitol. The columns 
were washed successively with 5 ml of equilibration buffer, 5 ml of 
equilibration buffer plus 0.1 M NaCl, and 5 ml of equilibration buffer 
plus 1 M NaCl. 1 ml fractions were collected and protein detected using 
a bicinchoninic acid protein assays (Pierce) following the manufac- 
turer’s instructions. 
binding to some unidentified protein in the cell and in- 
hibiting its dephosphorylation or increasing its phospho- 
rylation by PKC. Consistent with these possibilities is the 
result of Morgan and Burgoyne [3] that the enhancement 
of secretion by 14-3-3 proteins proteins is greater if the 
cells are also treated with phorbol ester to stimulate 
PKC. 
References 
[l] Sara8an, T., Aunis, D. and Bader, M.-F. (1987) J. Biol. Chem. 
262, 16671-16676. 
[2] Wu, Y.N. and Wagner, P.D. (1991) FEBS L&t. 282, 197-199. 
[3] Morgan, A. and Burgoyne, R.D. (1992) Nature 355, 833-836. 
[4] Wu, Y.N., Vu, N.-D. and Wagner, PD. (1992) Biochem. J. 285, 
697-700. 
[5] Yamauchi, T., Nakata, H. and Fujisawa, H. (1981) J. Biol. Chem. 
256, 5404-5409. 
[6] Boston, P.F., Jackson, P. and Thompson, R.J. (1982) J. Neuro- 
them. 38, 1475-1482. 
[7l Ichimura, T., Sugano, H., Kuwano, R., Sunaya, T., Okuyama, T. 
and Isobe, T. (1991) J. Neurochem. 56, 1449-1451. 
[8] Ichimura, T., Isobe, T., Okuyama, T., Yamauchi, T. and Fujisawa, 
H. (1987) FEBS Lett. 219, 79-82. 
[9] Zupan, L.A., Steffens, D.L., Berry, C.A., Landt, M. and Gross, 
R.W. (1992) J. Biol. Chem. 267, 8707-8710. 
[lo] Morgan, A., Roth, D., Martin, H., Aitken, A. and Burgoyne, R.D. 
(1993) B&hem. Sot. Trans. 21,401-5. 
[ll] Toker, A., Ellis, C.A., Sellers, L.A. and Aitken, A. (1990) Eur. J. 
B&hem. 191, 421-429. 
[12] Toker, A., Sellers, L.A., Amess, B., Patel, Y., Harris, A. and 
Aitken, A. (1992) Eur. J. B&hem. 206,453+61. 
[13] Isobe, T., Hiyane, Y., Ichimura, T., Okuyama, T., Takahashi, N., 
Nakajo, S. and Nakaya, K. (1992) FEBS Lett. 308, 121-124. 
[ 141 Morgan, A. and Burgoyne, R.D. (1992) B&hem. J. 286,807-811. 
[15] Wu, Y.N., Yang, Y.C. and Wagner, P.D. (1992) J. Biol. Chem. 
267, 83968403. 
[16] Wagner, P.D. and Vu, N.-D. (1990) J. Biol. Chem. 265, 10352- 
U71 
WI 
1191 
WI 
[211 
WI 
1231 
1241 
1251 
WI 
ml 
WI 
~291 
1301 
[311 
1321 
10357. 
Walton, G.M., Bertics, P.J., Hudson, L.G., Vedvick, T.S. and Gill, 
G.N. (1987) Anal. B&hem. 161,425-437. 
Pato, M.D., Adelstein, R.S., Crouch, D., Safer, B., Ingebritsen, 
T.S. and Cohen, P. (1983) Eur. J. Biochem. 132, 283-287. 
Wagner, P.D. (1982) Methods Enzymol. 85,72-81. 
Adelstein, R.S. and Klee, C.B. (1981) J. Biol. Chem. 256, 7501- 
7509. 
Galindo, E., Zwiller, J., Bader, M.-F. and Aunis, D. (1992) Proc. 
Natl. Acad. Sci. USA 89,7398-7402. 
Ho&men, R.E., Zwiller, J., Daily, S.L., Khatra, B.S., Dukelow, 
M. and Boynton, A.L. (1991) J. Biol. Chem. 266, 6614-6619. 
Killilea, S.D., Aylward, J.H., Mellgreen, R.L. and Lee, E.Y.C. 
(1978) Arch. Biochem. Biophys. 191, 638-646. 
Zwiller, J., Ogasawara, E.M., Nakamoto, S.S. and Boynton, A.L. 
(1988) Biochem. Biophys. Res. Commun. 155, 767-772. 
Ishihara, H., Martin, B.L., Brautigan, D.L., Karaki, H., Ozaki, 
H., Kato, Y., Fusetani, N., Watabe, S., Hashimoto, K., Uemura, 
D. and Hartshome, D.J. (1989) B&hem. Biophys. Res. Commun. 
159, 871-877. 
Cohen, P. and Cohen, P.T.W. (1989) J. Biol. Chem. 264, 21435- 
21438. 
Heasley, L.E. and Johnson, G.L. (1989) Mol. Pharmacol. 35,331- 
338. 
Nishikawa, M., Hidaka, H. and Adelstein, R.S. (1983) J. Biol. 
Chem. 258, 14069-14072. 
House, C., Wettenhall, R.E.H. and Kemp, B.E. (1987) J. Biol. 
Chem. 262, 772-777. 
Isobe, T., Ichimura, T., Sunaya, T., Okuyama, T., Takahashi, N., 
Kuwano, R. and Takahashi, Y. (1991) J. Mol. Biol. 217, 125-132. 
Aitken, A., Collinge, D.B., van Heusden, B.P.H., Isobe, T., 
Roseboom, P.H., Rosenfeld, G. and Soll, J. (1992) Trends Bio- 
them. Sci. 17,498-501. 
Malencik, D.A., Anderson, S.R., Bohnert, J.L. and Shalitin, Y. 
(1982) Biochemistry 21,4031-4039. 
